The Earlier You Know

Much of the "War on Cancer" money goes to curing the disease but in the latest issue of Wired, Thomas Goetz writes about the Canary Foundation, which is focused on early detection.  There, researchers are working on developing biomarker blood tests -- using proteomics to pinpoint proteins -- and new imaging tools. "A good biomarker will tell us something we don't know.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.